Arrhythmogenic mechanisms in left ventricular hypertrophy

Europace

Volumn 2, Issue 3, 2000, Pages 216-223

  Wolk, R ^a  

^a MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

Author keywords

Arrhythmias; Hypertrophy; Ischaemia; Sudden death

Indexed keywords

HEART ARRHYTHMIA; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; REVIEW;

ARRHYTHMIA; HUMANS; HYPERTROPHY, LEFT VENTRICULAR;

EID: 0034232339     PISSN: 10995129     EISSN: None     Source Type: Journal    
DOI: 10.1053/eupc.2000.0110     Document Type: Article

References (115)

1. Kannel WB. Prevalence and natural history of electrocardiographic left ventricular hypertrophy. Am J Med. 75:1983;4-11.
2. Wolk R, Cobbe SM. Cardiac arrhythmias in hypertrophy. Sheridan DJ. Left Ventricular Hypertrophy. 1998;101-106 Churchill Livingstone, London.
3. Ghali JK, Kadakia S, Cooper RS, Liso Y. Impact of left ventricular hypertrophy on ventricular arrhythmias in the absence of coronary artery disease. J Am Coll Cardiol. 17:1991;1277-1282.
4. Schmieder RE, Messerli FH. Determinants of ventricular ectopy in hypertensive cardiac hypertrophy. Am Heart J. 123:1992;89-95.
5. Vester EG, Kuhls S, Ochiulet-Vester J, Vogt M, Strauer BE. Electrophysiological and therapeutic implications of cardiac arrhythmias in hypertension. Eur Heart J. 13:1992;70-81.
6. Lavie CJ Jr, Nunez BD, Garavaglia GE, Messerli FH. Hypertensive concentric left ventricular hypertrophy: when is ventricular ectopic activity increased. South Med J. 81:1988;696-700.
7. James MA, Jones JV. Ventricular arrhythmia in untreated newly presenting hypertensive patients compared with a matched normal population. J Hypertens. 7:1989;409-415.
8. Manyari DE, Patterson C, Johnson D, Melendez L, Kostuk WJ, Cape RD. Atrial and ventricular arrhythmias in asymptomatic active elderly subjects: correlation with left atrial size and left ventricular mass. Am Heart J. 119:1990;1069-1076.
9. Kowey P, Friehling TD, Sewter J. Electrophysiological effects of left ventricular hypertrophy. Effect of calcium and potassium channel blockade. Circulation. 83:1991;2067-2075.
10. Kowey PR, O'Brien R, Wu Y. Effect of gallopamil on electrophysiologic abnormalities and ventricular hypertrophy in the feline heart. Am Heart J. 124:1992;898-905.
11. Rials SJ, Wu Y, Ford N. Effect of left ventricular hypertrophy and its regression on ventricular electrophysiology and vulnerability to inducible arrhythmia in the feline heart. Circulation. 91:1995;426-430.
12. Gillis AM, Mathison HJ, Kulisz E, Lester WM. Dispersion of ventricular repolarization and ventricular fibrillation in left ventricular hypertrophy: influence of selective potassium channel blockers. J Pharmacol Exp Ther. 292:2000;381-386.
13. Messerli FH, Nuñez BD, Nuñez MM, Garavaglia GE, Schmieder RE, Ventura HO. Hypertension and sudden death: disparate effects of calcium entry blocker and diuretic therapy on cardiac dysrhythmias. Arch Intern Med. 149:1989;1263-1267.
14. Malerba M, Muiesan ML, Zulli R, Rizzoni D, Calebich S, Agabiti Rosei E. Ventricular arrhythmias and changes in blood pressure and left ventricular mass induced by antihypertensive treatment in hypertensive patients. J Hypertens. 9:1991;S162-4.
15. González-Fernández RA, Rivera M, Rodríguez PJ. Prevalence of ectopic ventricular activity after left ventricular mass regression. Am J Hypertens. 6:1993;308-313.
16. Kohya T, Yokoshiki H, Tohse N. Regression of left ventricular hypertrophy prevents ischaemia-induced lethal arrhythmias. Beneficial effect of angiotensin II blockade. Circ Res. 76:1995;892-899.
17. Brilla CG, Matsubara L, Weber KT. Advanced hypertensive heart disease in spontaneously hypertensive rat. Lisinopril-mediated regression of myocardial fibrosis. Hypertension. 28:1996;269-275.
18. Yokoshiki H, Kohya T, Tomita F. Restoration of action potential duration and transient outward current by regression of left ventricular hypertrophy. J Moll Cell Cardiol. 29:1997;1331-1339.
19. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 114:1991;345-352.
20. Devereaux R, Roman M, Ganau A, de Simone G, Okin P, Kligfield P. Cardiac and arterial hypertrophy and atherosclerosis in hypertension. Hypertension. 23:1994;802-809.
21. Levy D, Anderson KM, Plehn J, Savage DD, Christiansen JC, Castelli WP. Echocardiographically determined left ventricular structural and functional correlates of complex or frequent ventricular arrhythmias on one-hour ambulatory electrocardiographic monitoring. Am J Cardiol. 59:1987;836-840.
22. Nunez BD, Lavie CJ, Messerli FH, Schmieder RE, Garavaglia GE, Nunez M. Comparison of diastolic left ventricular filling and cardiac dysrhythmias in hypertensive patients with and without isolated septal hypertrophy. Am J Cardiol. 74:1994;585-589.
23. Bethge C, Motz W, Hehn AV, Strauer BE. Ventricular arrhythmia in hypertensive heart disease with and without heart failure. J Cardiovasc Pharmacol. 10:1987;S119-28.
24. Pye MP, Cobbe SM. Mechanisms of ventricular arrhythmias in cardiac failure and hypertrophy. Cardiovasc Res. 26:1992;740-750.
25. Hart G. Cellular electrophysiology in cardiac hypertrophy and failure. Cardiovasc Res. 28:1994;933-946.
26. Boyden PA, Jeck CD. Ion channel function in disease. Cardiovasc Res. 29:1995;312-318.
27. Antzelevitch C, Sicouri S. Clinical relevance of cardiac arrhythmias generated by afterdepolarisations. Role of M cells in the generation of U waves, triggered activity and torsade de pointes. J Am Coll Cardiol. 23:1994;259-277.
28. Aronson RS. Afterpotentials and triggered activity in hypertrophied myocardium from rats with renal hypertension. Circ Res. 48:1981;720-727.
29. Ben-David J, Zipes DP, Ayers GM, Pride HP. Canine left ventricular hypertrophy predisposes to ventricular tachycardia induction by phase 2 early afterdepolarizations after administration of BAY K 8644. J Am Coll Cardiol. 20:1992;1576-1584.
30. Charpentier F, Baudet S, Le Marec H. Triggered activity as a possible mechanism for arrhythmias in ventricular hypertrophy. PACE. 14:1991;1735-1741.
31. Bryant SM, Shipsey SJ, Hart G. Regional differences in electrical and mechanical properties of myocytes from guinea-pig hearts with mild left ventricular hypertrophy. Cardiovasc Res. 35:1997;315-323.
32. Shipsey SJ, Bryant SM, Hart G. Effects of hypertrophy on regional action potential characteristics in the rat left ventricle. A cellular basis for T-wave inversion. Circulation. 96:1997;2061-2068.
33. McIntosh MA, Cobbe SM, Kane KA, Rankin AC. Action potential prolongation and potassium currents in left ventricular myocytes isolated from hypertrophied rabbit hearts. J Mol Cell Cardiol. 30:1998;43-53.
34. Wolk, R, Sneddon, KP, Kane, KA, Cobbe, SM, Hicks, MN, Regional electrophysiological effects of left ventricular hypertrophy in isolated whole hearts under normal and ischaemic conditions, Cardiovasc Res.
35. Cameron JS, Miller LS, Kimura S. Systemic hypertension induces disparate localized left ventricular action potential lengthening and altered sensitivity to verapamil in left ventricular myocardium. J Mol Cell Cardiol. 18:1986;169-175.
36. Carré F, Rannou F, Sainte Beuve C. Arrhythmogenicity of the hypertrophied and senescent heart in relationship to membrane proteins involved in the altered calcium handling. Cardiovasc Res. 27:1993;1784-1789.
37. Gwathmey JK, Morgan JP. Altered calcium handling in experimental pressure-overload hypertrophy in the ferret. Circ Res. 57:1985;836-843.
38. Merillat JC, Lakatta EG, Hano O, Guarnieri T. Role of calcium and the calcium channel in the initiation and maintenance of ventricular fibrillation. Circ Res. 67:1990;1115-1123.
39. Perreault CL, Williams CP, Morgan JP. Cytoplasmic calcium modulation and systolic versus diastolic dysfunction in myocardial hypertrophy and failure. Circulation. 87:1993;31-37.
40. Swynghedauw B, Chevalier B, Charlemagne D, Mansier P, Carré F. Cardiac hypertrophy, arrhythmogenicity and the new myocardial phenotype. II. The cellular adaptational process. Cardiovasc Res. 35:1997;6-12.
41. Hittinger L, Ghaleh B, Edwards JG. Reduced subendocardial ryanodine receptors and consequent effects on cardiac function in conscious dogs with left ventricular hypertrophy. Circ Res. 84:1999;999-1006.
42. Winterton SJ, Turner MA, O'Gorman DJ, Flores NA, Sheridan DJ. Hypertrophy causes delayed conduction in human and guinea pig myocardium: accentuation during ischaemic perfusion. Cardiovasc Res. 28:1994;47-54.
43. Cooklin M, Wallis WRJ, Sheridan DJ, Fry CH. Changes in cell-to-cell electrical coupling associated with left ventricular hypertrophy. Circ Res. 80:1997;765-771.
44. Peters NS, Del Monte F, Macleod KT, Green CR, Poole-Wilson PA, Severs NJ. Increased cardiac myocyte gap-junctional membrane early in renovascular hypertension (Abstr). J Am Coll Cardiol. 21:1993;59A.
45. Peters NS, Green CR, Poole-Wilson PA, Severs NJ. Reduced content of connexin43 gap junctions in ventricular myocardium from hypertrophied and ischaemic human hearts. Circulation. 88:1993;864-875.
46. Bastide B, Neyses L, Ganten D, Paul M, Willecke K, Traub O. Gap junction protein connexin40 is preferentially expressed in vascular endothelium and conductive bundles of rat myocardium and is increased under hypertensive conditions. Circ Res. 73:1993;1138-1149.
47. Sepp R, Severs NJ, Gourdie RG. Altered patterns of cardiac intercellular junction distribution in hypertrophic cardiomyopathy. Heart. 76:1996;412-417.
48. Janse MJ. Reentrant arrhythmias. Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE. The Heart and the Cardiovascular System, 2nd edn. 1992;2055-2094 Raven Press, New York.
49. Weber KT, Janicki JS, Pick R. Collagen in the hypertrophied, pressure-overloaded myocardium. Circulation. 75:1987;I-40-I-47.
50. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation. 83:1991;1849-1865.
51. Assayag P, Carré F, Chevalier B, Delcayre C, Mansier P, Swynghedauw B. Compensated cardiac hypertrophy: arrhythmogenicity and the new myocardial phenotype. I. Fibrosis. Cardiovasc Res. 34:1997;439-444.
52. Spach MS, Josephson ME. Initiating reentry: the role of non-uniform anisotropy in small circuits. J Cardiovasc Electrophysiol. 5:1994;182-209.
53. f, in ventricular myocytes isolated from hypertensive rats. J Physiol. 481:1994;585-591.
54. fin ventricular myocytes from normotensive and hypertensive rats during aging. Circulation. 94:1996;1674-1681.
55. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Left ventricular mass and incidence of coronary heart disease in an elderly cohort: the Framingham Heart Study. Ann Intern Med. 110:1989;101-107.
56. Weber K, Sun Y, Guarda E. Structural remodeling in hypertensive heart disease and the role of hormones. Hypertension. 23:1994;869-877.
57. Scheler S, Motz W, Stauer B. Mechanism of angina pectoris in patients with systemic hypertension and normal epicardial coronary arteries by arteriogram. Am J Cardiol. 73:1994;478-482.
58. Wallbridge DR, Cobbe SM. Coronary haemodynamics in left ventricular hypertrophy. Heart. 75:1996;369-376.
59. Koyanagi S, Eastham C, Marcus ML. Effects of chronic hypertension and left ventricular hypertrophy on the incidence of sudden cardiac death after coronary artery occlusion in conscious dogs. Circulation. 65:1982;1192-1197.
60. Bélichard P, Pruneau D, Rochette L. Influence of spontaneous hypertension and cardiac hypertrophy on the severity of ischemic arrhythmias in the rat. Basic Res Cardiol. 83:1988;560-566.
61. Kohya T, Kimura S, Myerburg RJ, Bassett AL. Susceptibility of hypertrophied rat hearts to ventricular fibrillation during acute ischaemia. J Mol Cell Cardiol. 20:1988;159-168.
62. Martins JB, Kim W, Marcus ML. Chronic hypertension and left ventricular hypertrophy facilitate induction of sustained ventricular tachycardia in dogs 3 hours after left circumflex coronary occlusion. J Am Coll Cardiol. 14:1989;1365-1373.
63. Janse MJ, Wit AL. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischaemia and infarction. Physiol Rev. 69:1989;1049-1169.
64. Bélichard P, Pruneau D, Rouet R, Salzmann JL. Electrophysiological responses of hypertrophied rat myocardium to combined hypoxia, hyperkalemia, and acidosis. J Cardiovasc Pharmacol. 17:1991;S141-5.
65. Hicks MN, McIntosh MA, Kane KA, Rankin AC, Cobbe SM. The electrophysiology of rabbit hearts with left ventricular hypertrophy under normal and ischaemic conditions. Cardiovasc Res. 30:1995;181-186.
66. +channels are altered in hypertrophied ventricular myocytes. Am J Physiol. 255:1988;H1254-8.
67. +channels in hypertrophied cells: effect of pH (Abstr). Circulation. 86:1992;I-92.
68. Kdiffers in feline left ventricular hypertrophy. Am J Physiol. 266:1994;H1121-31.
69. ATPchannel responsiveness to exogenous and locally generated (glycolytic) ATP. J Mol Cell Cardiol. 29:1997;2837-2848.
70. 3H]Ouabain binding sites in sarcolemma prepared from hearts of spontaneously hypertensive rats. Hypertension. 5:1983;682-688.
71. Vermeulen JT, Tan HL, Rademaker H. Electrophysiologic and extracellular ionic changes during acute ischemia in failing and normal rabbit myocardium. J Mol Cell Cardiol. 28:1996;123-131.
72. Oldershaw PJ, Cameron IRC. The effects of long-standing hypertensive left ventricular hypertrophy on intracellular pH and intracellular electrolytes in rats. Int J Cardiol. 18:1988;143-149.
73. +buffering capacity in guinea-pig left ventricular hypertrophy induced by constriction of the thoracic aorta. Exp Physiol. 82:1997;227-230.
74. Schömig A. Catecholamines in myocardial ischaemia. Systemic and cardiac release. Circulation. 82:1990;II-13-II-22.
75. Schömig A, Haass M, Richardt G. Catecholamine release and arrhythmias in acute myocardial ischaemia. Eur Heart J. 12:1991;38-47.
76. Strasser RH, Marquetant R, Kübler W. Adrenergic receptors and sensitization of adenylyl cyclase in acute myocardial ischemia. Circulation. 82:1990;II-23-II-29.
77. Thandroyen FT, Muntz KH, Buja LM, Willerson JT. Alterations in β-adrenergic receptors, adenylate cyclase, and cyclic AMP concentrations during acute myocardial ischemia and reperfusion. Circulation. 82:1990;II-30-II-37.
78. Strasser RH, Marquetant R. Sensitization of the β-adrenergic system in acute myocardial ischaemia by a protein kinase C-dependent mechanism. Eur Heart J. 12:1991;48-53.
79. Postnov YV. An approach to the explanation of cell membrane alteration in primary hypertension. Hypertension. 15:1990;332-337.
80. +exchange rate and more alkaline intracellular pH set-point in essential hypertension: effects of protein kinase modulation in platelets. J Hypertens. 9:1991;1013-1019.
81. +exchanger. Circ Res. 77:1995;1192-1200.
82. +exchange activity in the spontaneously hypertensive perfused rat heart. J Mol Cell Cardiol. 27:1995;1475-1481.
83. Wolk R, Cobbe SM, Hicks MN, Kane KA. Functional, structural and dynamic bases of electrical heterogeneity in healthy and diseased cardiac muscle: implications for arrhythmogenesis and antiarrhythmic drug therapy. Pharmacology & Therapeutics. 84:1999;207-231.
84. Schwarz PJ, Priori SG. Sympathetic nervous system and cardiac arrhythmias. Zipes DP, Jalife J. Cardiac Electrophysiology. From Cell to Bedside. 1990;330-343 WB Saunders Co, Philadelphia.
85. Barron HV, Lesh MD. Autonomic nervous system and sudden cardiac death. J Am Coll Cardiol. 27:1996;1053-1060.
86. Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans: evidence from direct intraneural recordings. Hypertension. 14:1989;177-183.
87. Brush JE Jr, Eisenhofer G, Garty M. Cardiac norepinephrine kinetics in hypertrophic cardiomyopathy. Circulation. 79:1989;836-844.
88. Kelm M, Schäfer S, Mingers S. Left ventricular mass is linked to cardiac noradrenaline in normotensive and hypertensive patients. J Hypertens. 14:1996;1357-1364.
89. Agabiti-Rosei G, Malerba M, Rizzoni D. Ventricular arrhythmias as related to adrenergic activity in untreated patients with cardiac hypertrophy (Abstr). Am J Hypertens. 3:1990;2A.
90. Coumel P. Cardiac arrhythmias and the autonomic nervous system. J Cardiovasc Electrophysiol. 4:1993;338-555.
91. Schillaci G, Verdecchia P, Borgioni C. Association between persistent pressure overload and ventricular arrhythmias in essential hypertension. Hypertension. 28:1996;284-289.
92. Martinez ML, Fernandez-Tome P, Lopez-Miranda V, Colado MI, Delgado C. Modulation of adrenergic receptors during left ventricular hypertrophy development and after regression by captopril. J Cardiovasc Pharmacol. 34:1999;505-511.
93. Scholz PM, Upsher ME, Eliades D, Kedem J, Weiss HR. Alterations in the regional beta adrenergic system in experimental left ventricular hypertrophy. Cardiovasc Res. 24:1990;65-71.
94. Ganguly PK, Lee SL, Beamish RE, Dhalla NS. Altered sympathetic system and adrenoceptors during the development of cardiac hypertrophy. Am Heart J. 118:1989;520-525.
95. Galinier M, Senard JM, Valet P. Cardiac beta-adrenoceptors and adenylyl cyclase activity in human left ventricular hypertrophy due to pressure overload. Fundam Clin Pharmacol. 8:1994;90-99.
96. Ayobe MH, Tarazi RC. Beta-receptors and contractile reserve in left ventricular hypertrophy. Hypertension. 5:1983;1192-1197.
97. Bohm M, Beuckelmann D, Diet F, Feiler G, Lohse MJ, Erdmann E. Properties of cardiac alpha- and beta-adrenoceptors in spontaneously hypertensive rats. Naunyn Schmiedebergs Arch Pharmacol. 338:1988;383-391.
98. Bohm M, Beuckelmann D, Brown L. Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium. Eur Heart J. 9:1988;844-852.
99. Franz MR. Stretch-activated arrhythmias. Zipes DP, Jalife J. Cardiac Electrophysiology. From Cell to Bedside, 2nd edn. 1994;597-606 W.B. Saunders Co, Philadelphia.
100. Sideris DA, Kontoyannis DA, Michalis L, Adractas A, Moulopoulos SD. Acute changes in blood pressure as a cause of cardiac arrhythmias. Eur Heart J. 8:1987;45-52.
101. Taggart P, Sutton P, Lab MJ, Runnals M, Obrian W, Treasure T. Effect of abrupt changes in ventricular loading on repolarization induced by transient aortic occlusion in humans. Am J Physiol. 263:1992;H816-23.
102. James MA, Jones JV. The paradoxical role of left ventricular hypertrophy in wall stress-related arrhythmia. J Hypertens. 10:1992;167-172.
103. Jauch W, Hicks MN, Cobbe SM. Effects of contraction-excitation feedback on electrophysiology and arrhythmogenesis in rabbits with experimental left ventricular hypertrophy. Cardiovasc Res. 28:1994;1390-1396.
104. Evans SJ, Levi AJ, Jones JV. Wall stress induced arrhythmia is enhanced by low potassium and early ventricular hypertrophy in the working rat heart. Cardiovasc Res. 29:1995;555-562.
105. Evans SJ, Levi AJ, Jones JV. Low magnesium enhances the pro-arrhythmic effect of low potassium in the hypertrophied rat heart but not in the normal rat heart. J Hypertens. 14:1996;635-644.
106. Helfant RH. Hypokalemia and arrhythmias. Am J Med. 80:1986;13-22.
107. Gettes LS. Electrolyte abnormalities underlying lethal and ventricular arrhythmias. Circulation. 85:1992;I-70-I-76.
108. Caralis PV, Materson BJ, Perez-Stable E. Potassium and diuretic induced ventricular arrhythmias in ambulatory hypertensive patients. Miner Electrolyte Metab. 10:1984;148-154.
109. Hollifield JW. Thiazide treatment of hypertension. Effects of thiazide diuretics on serum potassium, magnesium, and ventricular ectopy. Am J Med. 80:1986;8-12.
110. Cohen JD, Neaton JD, Prineas RJ. Diuretics, serum potassium and ventricular arrhythmias in the multiple risk factor intervention trial. Am J Cardiol. 60:1987;548-554.
111. Ryan MP. The effects of diuretics on magnesium and potassium homeostasis. Itokawa Y, Durlach J. Magnesium in Health and Disease. 1989;397-408 John Libbey and Co. Ltd, Paris.
112. James MA, Jones JV. Ventricular arrhythmia in untreated newly presenting hypertensive patients compared with a matched normal population. J Hypertens. 7:1989;409-415.
113. JAMA. 248:1982;1465-1477.
114. Holme I, Helgland A, Hjermann I, Leren P, Lund-Larsen P. Treatment of mild hypertension with diuretics. JAMA. 251:1984;1298-1299.
115. Br Med J. 291:1985;97-104.